Dual targeting of CCR2⁺ TAM and CXCR2⁺ TAN improves antitumour immunity and chemotherapeutic response in PDAC compared with either strategy alone.
No takes yet. Share an insight, caveat, or question.
Nywening et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Gut